Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis
Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conduct...
Saved in:
| Published in | Breast (Edinburgh) Vol. 78; p. 103807 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.12.2024
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions.
A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type.
Seventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9–12.5 %) for LCIS, 6.6 % (95 % CI 4.4–9.7 %) for ADH, 9.7 % (95 % CI 5.3–17.2 %) for ALH, 8.6 % (95 % CI 6.5–11.4 %) for LN, and 3.8 % (95 % CI 1.2–11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0–15.3 %) for LCIS, 13.9 % (95 % CI 7.8–23.6 %) for ADH, 15.4 % (95 % CI 7.2–29.3 %) for ALH, 17.0 % (95 % CI 7.2–35.3 %) for LN and 7.2 % (95 % CI 2.2–21.2 %) for FEA.
Our findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA.
•Cumulative breast cancer risk varies by time from initial lesion and by lesion type.•Moderate/high breast cancer risk shown within 10 years from initial high-risk lesion.•There is relatively less evidence of breast cancer risk after flat epithelial atypia. |
|---|---|
| AbstractList | Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions.
A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type.
Seventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9–12.5 %) for LCIS, 6.6 % (95 % CI 4.4–9.7 %) for ADH, 9.7 % (95 % CI 5.3–17.2 %) for ALH, 8.6 % (95 % CI 6.5–11.4 %) for LN, and 3.8 % (95 % CI 1.2–11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0–15.3 %) for LCIS, 13.9 % (95 % CI 7.8–23.6 %) for ADH, 15.4 % (95 % CI 7.2–29.3 %) for ALH, 17.0 % (95 % CI 7.2–35.3 %) for LN and 7.2 % (95 % CI 2.2–21.2 %) for FEA.
Our findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA.
•Cumulative breast cancer risk varies by time from initial lesion and by lesion type.•Moderate/high breast cancer risk shown within 10 years from initial high-risk lesion.•There is relatively less evidence of breast cancer risk after flat epithelial atypia. Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions. A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type. Seventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9-12.5 %) for LCIS, 6.6 % (95 % CI 4.4-9.7 %) for ADH, 9.7 % (95 % CI 5.3-17.2 %) for ALH, 8.6 % (95 % CI 6.5-11.4 %) for LN, and 3.8 % (95 % CI 1.2-11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0-15.3 %) for LCIS, 13.9 % (95 % CI 7.8-23.6 %) for ADH, 15.4 % (95 % CI 7.2-29.3 %) for ALH, 17.0 % (95 % CI 7.2-35.3 %) for LN and 7.2 % (95 % CI 2.2-21.2 %) for FEA. Our findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA. • Cumulative breast cancer risk varies by time from initial lesion and by lesion type. • Moderate/high breast cancer risk shown within 10 years from initial high-risk lesion. • There is relatively less evidence of breast cancer risk after flat epithelial atypia. Background: Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions. Methods: A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type. Results: Seventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9–12.5 %) for LCIS, 6.6 % (95 % CI 4.4–9.7 %) for ADH, 9.7 % (95 % CI 5.3–17.2 %) for ALH, 8.6 % (95 % CI 6.5–11.4 %) for LN, and 3.8 % (95 % CI 1.2–11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0–15.3 %) for LCIS, 13.9 % (95 % CI 7.8–23.6 %) for ADH, 15.4 % (95 % CI 7.2–29.3 %) for ALH, 17.0 % (95 % CI 7.2–35.3 %) for LN and 7.2 % (95 % CI 2.2–21.2 %) for FEA. Conclusion: Our findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA. Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions.BACKGROUNDBiopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat epithelial atypia (FEA) increase subsequent risk of breast cancer (BC), but long-term risk has not been synthesized. A systematic review was conducted to quantify future risk of breast cancer accounting for time since diagnosis of these high-risk lesions.A systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type.METHODSA systematic search of literature from 2000 was performed to identify studies reporting BC as an outcome following core-needle or excision biopsy histology diagnosis of ADH, ALH, LCIS, lobular neoplasia (LN) or FEA. Meta-analyses were conducted to estimate cumulative BC incidence at five-yearly intervals following initial diagnosis for each histology type.Seventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9-12.5 %) for LCIS, 6.6 % (95 % CI 4.4-9.7 %) for ADH, 9.7 % (95 % CI 5.3-17.2 %) for ALH, 8.6 % (95 % CI 6.5-11.4 %) for LN, and 3.8 % (95 % CI 1.2-11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0-15.3 %) for LCIS, 13.9 % (95 % CI 7.8-23.6 %) for ADH, 15.4 % (95 % CI 7.2-29.3 %) for ALH, 17.0 % (95 % CI 7.2-35.3 %) for LN and 7.2 % (95 % CI 2.2-21.2 %) for FEA.RESULTSSeventy studies reporting on 47,671 subjects met eligibility criteria. BC incidence at five years post-diagnosis with a high-risk lesion was estimated to be 9.3 % (95 % CI 6.9-12.5 %) for LCIS, 6.6 % (95 % CI 4.4-9.7 %) for ADH, 9.7 % (95 % CI 5.3-17.2 %) for ALH, 8.6 % (95 % CI 6.5-11.4 %) for LN, and 3.8 % (95 % CI 1.2-11.7 %) for FEA. At ten years post-diagnosis, BC incidence was estimated to be 11.8 % (95 % CI 9.0-15.3 %) for LCIS, 13.9 % (95 % CI 7.8-23.6 %) for ADH, 15.4 % (95 % CI 7.2-29.3 %) for ALH, 17.0 % (95 % CI 7.2-35.3 %) for LN and 7.2 % (95 % CI 2.2-21.2 %) for FEA.Our findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA.CONCLUSIONOur findings demonstrate increased BC risk sustained over time since initial diagnosis of high-risk breast lesions, varying by lesion type, with relatively less evidence for FEA. |
| ArticleNumber | 103807 |
| Author | Noguchi, Naomi Houssami, Nehmat Salisbury, Elizabeth Baker, Jannah Marinovich, M Luke Sprague, Brian L. |
| Author_xml | – sequence: 1 givenname: Jannah orcidid: 0000-0002-2208-6584 surname: Baker fullname: Baker, Jannah email: jannah.baker@sydney.edu.au organization: The Daffodil Centre, University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia – sequence: 2 givenname: Naomi surname: Noguchi fullname: Noguchi, Naomi organization: School of Public Health, Faculty of Health and Medicine, University of Sydney, Sydney, NSW, Australia – sequence: 3 givenname: M Luke surname: Marinovich fullname: Marinovich, M Luke organization: The Daffodil Centre, University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia – sequence: 4 givenname: Brian L. surname: Sprague fullname: Sprague, Brian L. organization: Departments of Surgery and Radiology, University of Vermont Cancer Center, Burlington, VT, USA – sequence: 5 givenname: Elizabeth surname: Salisbury fullname: Salisbury, Elizabeth organization: University of Sydney, Western Clinical School, Westmead Hospital, NSW, Australia – sequence: 6 givenname: Nehmat surname: Houssami fullname: Houssami, Nehmat organization: The Daffodil Centre, University of Sydney, a Joint Venture with Cancer Council NSW, Sydney, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39270543$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v1DAQhiNURLeFf4CQjxyaxY7ziRCoqvioVIkDcLYmznjXWycOtrMov4k_ibcpK8qlp5HG7_vMeGbOkpPBDpgkLxldM8rKN7t16xB8WGc0y2OK17R6kqxYwbOU05qeJCvalDRtqqo8Tc6831FKG17Wz5JT3mQVLXK-Sn5fhnnUEgzpJhlisI4Y204GHNnOI7rRgNdwcUxKcFIPtgeih9TrMF0QZSAQHHXYotERAQdktMDQETWFySFx2t8Sq0iHezR21MOGLN1H3iDRvSXfZh-wh6AlcbjX-OvO3mOAFAYws9f-efJUgfH44j6eJz8-ffx-9SW9-fr5-uryJpXx7yHNmrbuVM1KqoqiqCsskdNWlS2UVQU141wyDhyQ1aqpqzxHVcss50WhctXVOT9PrhduZ2EnRqd7cLOwoMVdwrqNABcbNShaBVih7EooIa9500BXsqykwFiXxxhZHxbWOLU9dhKH4MA8gD58GfRWbOxeMJaz2H0TCa_vCc7-nNAH0Wsv0RgY0E5ecEbzgldZk0Xpq3-LHav8XXcU5ItAOuu9Q3WUMCoOVyV2YtmLOFyVWK4q2t4vNoxTj7txwkuNcW-ddihDHIt-DPDuP4A0ejic3S3Oj9v_AMyn70k |
| Cites_doi | 10.1111/tbj.14117 10.1016/j.pathol.2015.11.015 10.1016/0046-8177(91)90105-X 10.1002/path.2808 10.1023/A:1008935821885 10.1016/j.breast.2018.03.012 10.1007/BF02966402 10.1002/ijc.20870 10.1007/s10549-017-4320-7 10.1200/JCO.2010.28.0784 10.1007/s10552-010-9508-7 10.1158/1940-6207.CAPR-12-0175 10.1245/s10434-024-14947-0 10.1097/00000478-200204000-00003 10.1111/tbj.14085 10.1002/cncr.32330 10.1245/s10434-021-10827-z 10.1007/s00330-021-08118-y 10.1007/s10549-014-3254-6 10.1016/S0140-6736(03)12230-1 10.1007/s00330-014-3132-y 10.1002/cncr.31061 10.1002/ijc.28803 10.1002/1097-0142(20010815)92:4<738::AID-CNCR1377>3.0.CO;2-Z 10.1007/s10549-008-0198-8 10.6004/jnccn.2023.0046 10.1093/jnci/djt124 10.3233/BD-201031 10.1259/bjr.20160595 10.1016/j.breast.2021.07.020 10.1001/jamaoncol.2016.3022 10.1002/cncr.23415 10.1245/s10434-010-1340-5 10.1002/cncr.29766 10.1016/S2214-109X(20)30215-1 10.1111/tbj.14097 10.3322/caac.21660 10.1016/j.jss.2019.03.047 10.1177/000313480807400218 10.1002/cam4.223 10.1016/j.acra.2021.09.009 10.3390/cancers15133521 10.1002/cncr.29775 10.1002/cncr.29243 10.1016/j.breast.2015.01.006 10.1007/s00428-007-0499-z 10.1148/radiol.11111293 10.1245/s10434-017-5867-6 10.1245/s10434-012-2719-2 10.1097/SLA.0000000000004849 10.1093/jnci/djw276 10.1371/journal.pone.0248930 10.1177/0003134820943546 10.1259/bjr.20180003 10.1158/1940-6207.CAPR-19-0051 10.1056/NEJMoa1103507 10.2214/AJR.20.25072 10.1245/s10434-019-08126-9 10.1016/j.clbc.2016.06.003 10.1200/JCO.2015.60.8869 10.1016/j.amjsurg.2006.06.024 10.1002/cncr.30153 10.1245/s10434-022-12313-6 10.1111/j.1524-4741.2007.00388.x 10.1007/s10549-007-9557-0 10.1259/bjr.20170484 10.1016/j.recesp.2021.06.016 10.1158/1055-9965.EPI-06-0394 10.1245/s10434-018-6937-0 10.1038/s41416-018-0120-z 10.1245/s10434-020-08476-9 10.1016/j.ejso.2023.107292 10.1007/s10549-017-4347-9 10.1016/j.amjsurg.2006.06.015 10.1007/s10549-014-3208-z 10.1016/j.arcmed.2020.09.011 10.5152/dir.2014.14023 10.5858/arpa.2017-0155-OA 10.1186/s12957-021-02182-w 10.1056/NEJMoa044383 10.1007/s10549-012-2318-8 |
| ContentType | Journal Article |
| Copyright | 2024 The Authors Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. 2024 The Authors 2024 |
| Copyright_xml | – notice: 2024 The Authors – notice: Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2024 The Authors 2024 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1016/j.breast.2024.103807 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-3080 |
| ExternalDocumentID | oai_doaj_org_article_bfae7ecd6a6a48399ad61260a11d4260 PMC11415589 39270543 10_1016_j_breast_2024_103807 S0960977624001383 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA282725 |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HEC HMK HMO HVGLF HZ~ IHE J1W KOM L7B M29 M2X M41 MO0 N9A O-L O9- OAUVE OC~ OK1 OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPM RPZ SAE SCC SDF SDG SDP SEL SES SEW SSH SSZ T5K WUQ Z5R ~G- 6I. AACTN AAFTH AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c532t-29b8df8160f55587e6e30bf6ba677a8133c13a3ae18f98744ef8c24355f4fd843 |
| IEDL.DBID | DOA |
| ISSN | 0960-9776 1532-3080 |
| IngestDate | Wed Aug 27 01:26:25 EDT 2025 Thu Aug 21 18:34:14 EDT 2025 Mon Jul 21 11:13:41 EDT 2025 Tue Jul 22 01:42:05 EDT 2025 Tue Jul 01 03:59:19 EDT 2025 Sat Dec 14 16:14:39 EST 2024 Tue Aug 26 18:59:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Atypical proliferations Lobular carcinoma in-situ Breast cancer risk Breast cancer Mammography Biopsy |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c532t-29b8df8160f55587e6e30bf6ba677a8133c13a3ae18f98744ef8c24355f4fd843 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-4 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-2208-6584 |
| OpenAccessLink | https://doaj.org/article/bfae7ecd6a6a48399ad61260a11d4260 |
| PMID | 39270543 |
| PQID | 3104537292 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_bfae7ecd6a6a48399ad61260a11d4260 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11415589 proquest_miscellaneous_3104537292 pubmed_primary_39270543 crossref_primary_10_1016_j_breast_2024_103807 elsevier_sciencedirect_doi_10_1016_j_breast_2024_103807 elsevier_clinicalkey_doi_10_1016_j_breast_2024_103807 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-12-01 |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Breast (Edinburgh) |
| PublicationTitleAlternate | Breast |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – sequence: 0 name: Elsevier Ltd – name: Elsevier Ltd – name: Elsevier |
| References | Sergesketter, Thomas, Fayanju (bib68) 2019; 241 Bevers, Niell, Baker (bib86) 2023; 21 van Maaren, Avila, van Manen (bib78) 2021; 59 Kilgore, Yi, Bevers (bib43) 2022; 276 Miller, Thomas, Sergesketter (bib53) 2022; 29 Cote, Ruterbusch, Alosh (bib3) 2012; 5 Middleton, Sneige, Coyne (bib52) 2014; 3 Alvarado-Cabrero, Valencia-Cedillo, Estevez-Castro (bib15) 2020; 51 Byrne, Schairer, Brinton (bib31) 2001; 12 Sung, Ferlay, Siegel (bib1) 2021; 71 Degnim, Dupont, Radisky (bib35) 2016; 122 Lilleborge, Falk, Russnes (bib46) 2019; 125 Muller, Roberts, Zhao, Jorns (bib56) 2018; 142 Donaldson, McCarthy, Goraya (bib36) 2018; 124 Minami, Zabor, Gilbert (bib55) 2020; 27 Dunne, Quinn, Stokes (bib37) 2021; 40 Bellini, Nori Cucchiari, Di Naro (bib27) 2023; 15 Calhoun (bib12) 2021; 216 Shaaban, Sloane, West (bib69) 2002; 26 Acevedo, Armengol, Deng (bib22) 2019 Boland, Dunne, Kovanaite (bib28) 2020; 26 Provencher, Jacob, Cote (bib63) 2012; 263 Susnik, Day, Abeln (bib73) 2016; 16 (bib20) 2018 Goss, Ingle, Ales-Martinez (bib39) 2011; 364 Metovic, Abate, Borella (bib51) 2021; 19 Baker, Houssami, Salisbury, Marinovich, Noguchi (bib18) 2023 Worsham, Abrams, Raju (bib82) 2007; 13 Page, McKenzie, Bossuyt (bib21) 2021; 74 Greene, Tartter, Smith, Estabrook (bib40) 2006; 192 Aulmann, Penzel, Longerich (bib26) 2008; 107 Tice, O'Meara, Weaver (bib75) 2013; 105 Collins, Aroner, Connolly (bib33) 2016; 122 Mazzola, Coopey, Griffin (bib50) 2017; 165 Whiffen, El-Tamer, Taback, Feldman, Joseph (bib80) 2011; 18 Louro, Roman, Posso (bib48) 2021; 16 Miller-Ocuin, Fowler, Coldren (bib54) 2020; 86 Chun, El-Tamer, Joseph, Ditkoff, Schnabel (bib32) 2006; 192 Adams (bib8) 2010; 2 Stefano, Carla, Giancarlo (bib72) 2014; 24 Wells, Shea, O'Connell (bib19) 2021 Page, Kidd, Dupont, Simpson, Rogers (bib7) 1991; 22 Bombonati, Sgroi (bib9) 2011; 223 Buckley, Sullivan, Farshid, Hiller, Roder (bib30) 2015; 24 Kabat, Jones, Olson (bib41) 2010; 21 Castells, Domingo, Corominas (bib5) 2015; 149 Arthur, Wang, Ye (bib24) 2017; 165 Worsham, Raju, Lu (bib83) 2009; 118 Karimi, Phillips, Brook (bib42) 2022; 29 Lo, Milne, Liao (bib47) 2018; 119 Poola, Yue, Gillespie (bib61) 2019; 12 Choi, Eaton, Olcese (bib10) 2013; 20 Laws, Katlin, Nakhlis (bib44) 2022; 29 Page, Schuyler, Dupont (bib60) 2003; 361 Visscher, Frost, Hartmann (bib79) 2016; 122 Tice, Miglioretti, Li (bib76) 2015; 33 Yoon, Koo, Lee (bib84) 2020; 27 Schiaffino, Massone, Gristina (bib67) 2018; 91 Sohn, Arthurs, Kim, Brown (bib71) 2008; 74 Hartmann, Sellers, Frost (bib4) 2005; 353 Menes, Kerlikowske, Lange (bib17) 2017; 3 Schiaffino, Gristina, Villa (bib66) 2018; 91 Wong, King, Boileau, Barry, Golshan (bib81) 2017; 24 Ashbeck, Rosenberg, Stauber, Key (bib25) 2007; 16 Martel, Barron-Rodriguez, Tolgay Ocal, Dotto, Tavassoli (bib49) 2007; 451 Heer, Harper, Escandor (bib2) 2020; 8 Sharma, Wilkinson, Pinder (bib13) 2017; 90 Kerlikowske, Gard, Tice (bib6) 2017; 109 Nakhlis, Harrison, Giess (bib58) 2019; 26 Posso, Alcantara, Vazquez (bib62) 2022; 32 Said, Visscher, Nassar (bib65) 2015; 121 Nagi, O'Donnell, Tismenetsky, Bleiweiss, Jaffer (bib57) 2008; 112 Boughey, Hartmann, Anderson (bib29) 2010; 28 Goldstein, Kestin, Vicini (bib38) 2001; 92 Akashi-Tanaka, Fukutomi, Nanasawa (bib74) 2000; 7 Adams, Falcon, Mooney (bib23) 2014; 20 Singh, Sung, Quddus (bib70) 2020; 26 Levi, Randimbison, Te, La Vecchia (bib45) 2005; 116 Laws, Leonard, Hershey (bib16) 2024; 31 Dyrstad, Yan, Fowler, Colditz (bib11) 2015; 149 Zarwan, Diamond, Lam (bib85) 2021; 27 Ouldamer, Poisson, Arbion (bib59) 2018; 40 Coopey, Mazzola, Buckley (bib34) 2012; 136 Renshaw, Gould (bib64) 2016; 48 To, Wall, Baines, Miller (bib77) 2014; 135 Rubio, Wyld, Marotti (bib14) 2024; 50 Kerlikowske (10.1016/j.breast.2024.103807_bib6) 2017; 109 Singh (10.1016/j.breast.2024.103807_bib70) 2020; 26 Hartmann (10.1016/j.breast.2024.103807_bib4) 2005; 353 Louro (10.1016/j.breast.2024.103807_bib48) 2021; 16 Wells (10.1016/j.breast.2024.103807_bib19) 2021 Dunne (10.1016/j.breast.2024.103807_bib37) 2021; 40 Tice (10.1016/j.breast.2024.103807_bib75) 2013; 105 Buckley (10.1016/j.breast.2024.103807_bib30) 2015; 24 Alvarado-Cabrero (10.1016/j.breast.2024.103807_bib15) 2020; 51 Renshaw (10.1016/j.breast.2024.103807_bib64) 2016; 48 Minami (10.1016/j.breast.2024.103807_bib55) 2020; 27 Susnik (10.1016/j.breast.2024.103807_bib73) 2016; 16 van Maaren (10.1016/j.breast.2024.103807_bib78) 2021; 59 Collins (10.1016/j.breast.2024.103807_bib33) 2016; 122 Donaldson (10.1016/j.breast.2024.103807_bib36) 2018; 124 Choi (10.1016/j.breast.2024.103807_bib10) 2013; 20 Chun (10.1016/j.breast.2024.103807_bib32) 2006; 192 Karimi (10.1016/j.breast.2024.103807_bib42) 2022; 29 Sung (10.1016/j.breast.2024.103807_bib1) 2021; 71 Laws (10.1016/j.breast.2024.103807_bib16) 2024; 31 Byrne (10.1016/j.breast.2024.103807_bib31) 2001; 12 Kilgore (10.1016/j.breast.2024.103807_bib43) 2022; 276 Schiaffino (10.1016/j.breast.2024.103807_bib67) 2018; 91 Degnim (10.1016/j.breast.2024.103807_bib35) 2016; 122 Tice (10.1016/j.breast.2024.103807_bib76) 2015; 33 Aulmann (10.1016/j.breast.2024.103807_bib26) 2008; 107 Posso (10.1016/j.breast.2024.103807_bib62) 2022; 32 Ashbeck (10.1016/j.breast.2024.103807_bib25) 2007; 16 Greene (10.1016/j.breast.2024.103807_bib40) 2006; 192 Schiaffino (10.1016/j.breast.2024.103807_bib66) 2018; 91 Mazzola (10.1016/j.breast.2024.103807_bib50) 2017; 165 Page (10.1016/j.breast.2024.103807_bib7) 1991; 22 Sohn (10.1016/j.breast.2024.103807_bib71) 2008; 74 Lo (10.1016/j.breast.2024.103807_bib47) 2018; 119 Adams (10.1016/j.breast.2024.103807_bib23) 2014; 20 Castells (10.1016/j.breast.2024.103807_bib5) 2015; 149 Acevedo (10.1016/j.breast.2024.103807_bib22) 2019 Poola (10.1016/j.breast.2024.103807_bib61) 2019; 12 Yoon (10.1016/j.breast.2024.103807_bib84) 2020; 27 Muller (10.1016/j.breast.2024.103807_bib56) 2018; 142 Nakhlis (10.1016/j.breast.2024.103807_bib58) 2019; 26 Heer (10.1016/j.breast.2024.103807_bib2) 2020; 8 Adams (10.1016/j.breast.2024.103807_bib8) 2010; 2 Calhoun (10.1016/j.breast.2024.103807_bib12) 2021; 216 Goss (10.1016/j.breast.2024.103807_bib39) 2011; 364 Visscher (10.1016/j.breast.2024.103807_bib79) 2016; 122 Bevers (10.1016/j.breast.2024.103807_bib86) 2023; 21 Dyrstad (10.1016/j.breast.2024.103807_bib11) 2015; 149 Provencher (10.1016/j.breast.2024.103807_bib63) 2012; 263 Akashi-Tanaka (10.1016/j.breast.2024.103807_bib74) 2000; 7 Sharma (10.1016/j.breast.2024.103807_bib13) 2017; 90 Rubio (10.1016/j.breast.2024.103807_bib14) 2024; 50 Ouldamer (10.1016/j.breast.2024.103807_bib59) 2018; 40 Wong (10.1016/j.breast.2024.103807_bib81) 2017; 24 Laws (10.1016/j.breast.2024.103807_bib44) 2022; 29 Miller (10.1016/j.breast.2024.103807_bib53) 2022; 29 Worsham (10.1016/j.breast.2024.103807_bib83) 2009; 118 Levi (10.1016/j.breast.2024.103807_bib45) 2005; 116 Baker (10.1016/j.breast.2024.103807_bib18) Miller-Ocuin (10.1016/j.breast.2024.103807_bib54) 2020; 86 Page (10.1016/j.breast.2024.103807_bib21) 2021; 74 Boughey (10.1016/j.breast.2024.103807_bib29) 2010; 28 Goldstein (10.1016/j.breast.2024.103807_bib38) 2001; 92 Kabat (10.1016/j.breast.2024.103807_bib41) 2010; 21 Boland (10.1016/j.breast.2024.103807_bib28) 2020; 26 Bellini (10.1016/j.breast.2024.103807_bib27) 2023; 15 Shaaban (10.1016/j.breast.2024.103807_bib69) 2002; 26 To (10.1016/j.breast.2024.103807_bib77) 2014; 135 Zarwan (10.1016/j.breast.2024.103807_bib85) 2021; 27 Coopey (10.1016/j.breast.2024.103807_bib34) 2012; 136 Lilleborge (10.1016/j.breast.2024.103807_bib46) 2019; 125 Menes (10.1016/j.breast.2024.103807_bib17) 2017; 3 Whiffen (10.1016/j.breast.2024.103807_bib80) 2011; 18 Sergesketter (10.1016/j.breast.2024.103807_bib68) 2019; 241 Cote (10.1016/j.breast.2024.103807_bib3) 2012; 5 Said (10.1016/j.breast.2024.103807_bib65) 2015; 121 Martel (10.1016/j.breast.2024.103807_bib49) 2007; 451 Stefano (10.1016/j.breast.2024.103807_bib72) 2014; 24 Middleton (10.1016/j.breast.2024.103807_bib52) 2014; 3 Metovic (10.1016/j.breast.2024.103807_bib51) 2021; 19 Arthur (10.1016/j.breast.2024.103807_bib24) 2017; 165 Worsham (10.1016/j.breast.2024.103807_bib82) 2007; 13 Bombonati (10.1016/j.breast.2024.103807_bib9) 2011; 223 Nagi (10.1016/j.breast.2024.103807_bib57) 2008; 112 Page (10.1016/j.breast.2024.103807_bib60) 2003; 361 |
| References_xml | – volume: 149 start-page: 237 year: 2015 end-page: 244 ident: bib5 article-title: Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program publication-title: Breast Cancer Res Treat – volume: 24 start-page: 208 year: 2015 end-page: 212 ident: bib30 article-title: Risk profile of breast cancer following atypical hyperplasia detected through organized screening publication-title: Breast – volume: 12 start-page: 103 year: 2001 end-page: 110 ident: bib31 article-title: Effects of mammographic density and benign breast disease on breast cancer risk (United States) publication-title: Cancer Causes Control – volume: 26 start-page: 55 year: 2019 end-page: 61 ident: bib58 article-title: Evaluating the rate of upgrade to invasive breast cancer and/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ publication-title: Ann Surg Oncol – volume: 40 start-page: 155 year: 2021 end-page: 160 ident: bib37 article-title: Upgrade rates and outcomes of screen-detected atypical intraductal epithelial proliferation (AIDEP) diagnosed on core needle biopsy publication-title: Breast Dis – volume: 20 start-page: 464 year: 2014 end-page: 469 ident: bib23 article-title: Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it? publication-title: Diagn Interv Radiol – volume: 16 start-page: 467 year: 2007 end-page: 472 ident: bib25 article-title: Benign breast biopsy diagnosis and subsequent risk of breast cancer publication-title: Cancer Epidemiology Biomarkers and Prevention – volume: 122 start-page: 378 year: 2016 end-page: 385 ident: bib79 article-title: Clinicopathologic features of breast cancers that develop in women with previous benign breast disease publication-title: Cancer – volume: 165 start-page: 623 year: 2017 end-page: 631 ident: bib24 article-title: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease publication-title: Breast Cancer Res Treat – volume: 263 start-page: 43 year: 2012 end-page: 52 ident: bib63 article-title: Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy publication-title: Radiology – volume: 21 start-page: 821 year: 2010 end-page: 828 ident: bib41 article-title: A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer publication-title: Cancer Causes Control – volume: 192 start-page: 499 year: 2006 end-page: 501 ident: bib40 article-title: The significance of surgical margins for patients with atypical ductal hyperplasia publication-title: Am J Surg – volume: 27 start-page: 1844 year: 2020 end-page: 1851 ident: bib55 article-title: Do body mass index and breast density impact cancer risk among women with lobular carcinoma in situ? publication-title: Ann Surg Oncol – volume: 91 year: 2018 ident: bib66 article-title: Flat epithelial atypia: conservative management of patients without residual microcalcifications post-vacuum-assisted breast biopsy publication-title: Br J Radiol – volume: 135 start-page: 1646 year: 2014 end-page: 1652 ident: bib77 article-title: Is carcinoma in situ a precursor lesion of invasive breast cancer? publication-title: Int J Cancer – volume: 29 start-page: 1029 year: 2022 end-page: 1038 ident: bib42 article-title: Upgrade rates of pure, radiology-pathology concordant lobular neoplasia diagnosed on breast core needle biopsy: is surgical excision warranted? publication-title: Acad Radiol – volume: 90 year: 2017 ident: bib13 article-title: The B3 conundrum-the radiologists' perspective publication-title: Br J Radiol – volume: 109 start-page: 5 year: 2017 ident: bib6 article-title: Risk factors that increase risk of estrogen receptor-positive and -negative breast cancer publication-title: J Natl Cancer Inst – volume: 7 start-page: 341 year: 2000 end-page: 344 ident: bib74 article-title: Treatment of noninvasive carcinoma: fifteen-year results at the national cancer center hospital in tokyo publication-title: Breast Cancer – volume: 353 start-page: 229 year: 2005 end-page: 237 ident: bib4 article-title: Benign breast disease and the risk of breast cancer publication-title: N Engl J Med – volume: 51 start-page: 845 year: 2020 end-page: 850 ident: bib15 article-title: Preneoplasia of the breast and molecular landscape publication-title: Arch Med Res – volume: 223 start-page: 307 year: 2011 end-page: 317 ident: bib9 article-title: The molecular pathology of breast cancer progression publication-title: J Pathol – volume: 216 start-page: 1432 year: 2021 end-page: 1433 ident: bib12 article-title: Management of high-risk breast lesions: point-surveillance is a change in practice preceding evidence-based standardization publication-title: AJR Am J Roentgenol – volume: 92 start-page: 738 year: 2001 end-page: 747 ident: bib38 article-title: Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast publication-title: Cancer – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: bib1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 8 start-page: e1027 year: 2020 end-page: e1037 ident: bib2 article-title: Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study publication-title: Lancet Glob Health – volume: 91 year: 2018 ident: bib67 article-title: Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia publication-title: Br J Radiol – volume: 451 start-page: 883 year: 2007 end-page: 891 ident: bib49 article-title: Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999) publication-title: Virchows Arch – year: 2019 ident: bib22 article-title: Incidental atypical hyperplasia/LCIS in mammoplasty specimens and subsequent risk of breast cancer – volume: 361 start-page: 125 year: 2003 end-page: 129 ident: bib60 article-title: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study publication-title: Lancet – volume: 105 start-page: 1043 year: 2013 end-page: 1049 ident: bib75 article-title: Benign breast disease, mammographic breast density, and the risk of breast cancer publication-title: J Natl Cancer Inst – volume: 16 start-page: 507 year: 2016 end-page: 513 ident: bib73 article-title: Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases publication-title: Clin Breast Cancer – volume: 122 start-page: 2971 year: 2016 end-page: 2978 ident: bib35 article-title: Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women publication-title: Cancer – volume: 165 start-page: 285 year: 2017 end-page: 291 ident: bib50 article-title: Reassessing risk models for atypical hyperplasia: age may not matter publication-title: Breast Cancer Res Treat – volume: 27 start-page: 3614 year: 2020 end-page: 3622 ident: bib84 article-title: Factors predicting breast cancer development in women during surveillance after surgery for atypical ductal hyperplasia of the breast: analysis of clinical, radiologic, and histopathologic features publication-title: Ann Surg Oncol – volume: 27 start-page: 48 year: 2021 end-page: 51 ident: bib85 article-title: Longitudinal study of breast cancer risk markers publication-title: Breast J – volume: 26 start-page: 2383 year: 2020 end-page: 2390 ident: bib28 article-title: Lobular intraepithelial neoplasia: outcomes and optimal management publication-title: Breast J – volume: 33 start-page: 3137 year: 2015 end-page: 3143 ident: bib76 article-title: Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer publication-title: J Clin Oncol – volume: 2 start-page: 90 year: 2010 end-page: 94 ident: bib8 article-title: Flat epithelial atypia: a review of current concepts publication-title: Open Breast Cancer J – volume: 59 start-page: 376 year: 2021 end-page: 382 ident: bib78 article-title: Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in The Netherlands: a population-based analysis publication-title: Breast – volume: 20 start-page: 1302 year: 2013 end-page: 1310 ident: bib10 article-title: Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer? publication-title: Ann Surg Oncol – volume: 26 start-page: 421 year: 2002 end-page: 430 ident: bib69 article-title: Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study publication-title: Am J Surg Pathol – volume: 24 start-page: 1651 year: 2014 end-page: 1658 ident: bib72 article-title: Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy publication-title: Eur Radiol – volume: 124 start-page: 459 year: 2018 end-page: 465 ident: bib36 article-title: Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy publication-title: Cancer – year: 2018 ident: bib20 article-title: CRAN-R project. rmeta: meta-Analysis – volume: 241 start-page: 188 year: 2019 end-page: 198 ident: bib68 article-title: The influence of age on the histopathology and prognosis of atypical breast lesions publication-title: J Surg Res – volume: 5 start-page: 1375 year: 2012 end-page: 1380 ident: bib3 article-title: Benign breast disease and the risk of subsequent breast cancer in African American women publication-title: Cancer Prev Res – volume: 18 start-page: 463 year: 2011 end-page: 467 ident: bib80 article-title: Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia publication-title: Ann Surg Oncol – volume: 24 start-page: 2509 year: 2017 end-page: 2517 ident: bib81 article-title: Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ publication-title: Ann Surg Oncol – volume: 74 start-page: 790 year: 2021 end-page: 799 ident: bib21 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: Rev Esp Cardiol – volume: 142 start-page: 391 year: 2018 end-page: 395 ident: bib56 article-title: Isolated atypical lobular hyperplasia diagnosed on breast biopsy: low upgrade rate on subsequent excision with long-term follow-up publication-title: Arch Pathol Lab Med – volume: 121 start-page: 1548 year: 2015 end-page: 1555 ident: bib65 article-title: Flat epithelial atypia and risk of breast cancer: a Mayo cohort study publication-title: Cancer – volume: 19 start-page: 80 year: 2021 ident: bib51 article-title: The lobular neoplasia enigma: management and prognosis in a long follow-up case series publication-title: World J Surg Oncol – volume: 29 start-page: 6484 year: 2022 end-page: 6494 ident: bib53 article-title: The influence of body mass index on the histopathology and outcomes of patients diagnosed with atypical breast lesions publication-title: Ann Surg Oncol – volume: 112 start-page: 2152 year: 2008 end-page: 2158 ident: bib57 article-title: Lobular neoplasia on core needle biopsy does not require excision publication-title: Cancer – volume: 50 year: 2024 ident: bib14 article-title: European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO publication-title: Eur J Surg Oncol – volume: 3 start-page: 36 year: 2017 end-page: 41 ident: bib17 article-title: Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy publication-title: JAMA Oncol – year: 2021 ident: bib19 article-title: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses – volume: 122 start-page: 515 year: 2016 end-page: 520 ident: bib33 article-title: Breast cancer risk by extent and type of atypical hyperplasia: an update from the Nurses' Health Studies publication-title: Cancer – volume: 119 start-page: 36 year: 2018 end-page: 39 ident: bib47 article-title: Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ publication-title: Br J Cancer – volume: 21 start-page: 900 year: 2023 end-page: 909 ident: bib86 article-title: NCCN guidelines(R) insights: breast cancer screening and diagnosis, version 1.2023 publication-title: J Natl Compr Canc Netw – volume: 16 year: 2021 ident: bib48 article-title: Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening publication-title: PLoS One – volume: 192 start-page: 474 year: 2006 end-page: 477 ident: bib32 article-title: Predictors of breast cancer development in a high-risk population publication-title: Am J Surg – volume: 74 start-page: 172 year: 2008 end-page: 177 ident: bib71 article-title: Lobular neoplasia: is surgical excision warranted? publication-title: Am Surg – volume: 15 start-page: 3521 year: 2023 ident: bib27 article-title: Breast lesions of uncertain malignant potential (B3) and the risk of breast cancer development: a long-term follow-up study publication-title: Cancers – volume: 13 start-page: 115 year: 2007 end-page: 121 ident: bib82 article-title: Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population publication-title: Breast J – volume: 276 start-page: e932 year: 2022 end-page: e936 ident: bib43 article-title: Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision publication-title: Ann Surg – volume: 32 start-page: 621 year: 2022 end-page: 629 ident: bib62 article-title: Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening publication-title: Eur Radiol – volume: 364 start-page: 2381 year: 2011 end-page: 2391 ident: bib39 article-title: Exemestane for breast-cancer prevention in postmenopausal women publication-title: N Engl J Med – volume: 31 start-page: 3120 year: 2024 end-page: 3127 ident: bib16 article-title: Upgrade rates and breast cancer development among germline pathogenic variant carriers with high-risk breast lesions publication-title: Ann Surg Oncol – year: 2023 ident: bib18 article-title: Atypical hyperplasia, lobular carcinoma in-situ, flat epithelial atypia and associated risk of developing breast cancer: National Institute for Health and Care Research – volume: 125 start-page: 3330 year: 2019 end-page: 3337 ident: bib46 article-title: Risk of breast cancer by prior screening results among women participating in BreastScreen Norway publication-title: Cancer – volume: 116 start-page: 820 year: 2005 end-page: 823 ident: bib45 article-title: Invasive breast cancer following ductal and lobular carcinoma in situ of the breast publication-title: Int J Cancer – volume: 86 start-page: 1088 year: 2020 end-page: 1090 ident: bib54 article-title: Is excisional biopsy needed for pure FEA diagnosed on a core biopsy? publication-title: Am Surg – volume: 48 start-page: 25 year: 2016 end-page: 29 ident: bib64 article-title: Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies publication-title: Pathology – volume: 22 start-page: 1232 year: 1991 end-page: 1239 ident: bib7 article-title: Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease publication-title: Hum Pathol – volume: 136 start-page: 627 year: 2012 end-page: 633 ident: bib34 article-title: The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions publication-title: Breast Cancer Res Treat – volume: 28 start-page: 3591 year: 2010 end-page: 3596 ident: bib29 article-title: Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia publication-title: J Clin Oncol – volume: 40 start-page: 4 year: 2018 end-page: 9 ident: bib59 article-title: All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision publication-title: Breast – volume: 12 start-page: 471 year: 2019 end-page: 480 ident: bib61 article-title: Breast hyperplasias, risk signature, and breast cancer publication-title: Cancer Prev Res – volume: 26 start-page: 2350 year: 2020 end-page: 2356 ident: bib70 article-title: Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy publication-title: Breast J – volume: 29 start-page: 1660 year: 2022 end-page: 1667 ident: bib44 article-title: Atypical lobular hyperplasia and classic lobular carcinoma in situ can Be safely managed without surgical excision publication-title: Ann Surg Oncol – volume: 118 start-page: 1 year: 2009 end-page: 7 ident: bib83 article-title: Risk factors for breast cancer from benign breast disease in a diverse population publication-title: Breast Cancer Res Treat – volume: 107 start-page: 331 year: 2008 end-page: 335 ident: bib26 article-title: Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer publication-title: Breast Cancer Res Treat – volume: 149 start-page: 569 year: 2015 end-page: 575 ident: bib11 article-title: Breast cancer risk associated with benign breast disease: systematic review and meta-analysis publication-title: Breast Cancer Res Treat – volume: 3 start-page: 492 year: 2014 end-page: 499 ident: bib52 article-title: Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting publication-title: Cancer Med – volume: 26 start-page: 2383 issue: 12 year: 2020 ident: 10.1016/j.breast.2024.103807_bib28 article-title: Lobular intraepithelial neoplasia: outcomes and optimal management publication-title: Breast J doi: 10.1111/tbj.14117 – volume: 48 start-page: 25 issue: 1 year: 2016 ident: 10.1016/j.breast.2024.103807_bib64 article-title: Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies publication-title: Pathology doi: 10.1016/j.pathol.2015.11.015 – volume: 22 start-page: 1232 issue: 12 year: 1991 ident: 10.1016/j.breast.2024.103807_bib7 article-title: Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease publication-title: Hum Pathol doi: 10.1016/0046-8177(91)90105-X – volume: 223 start-page: 307 issue: 2 year: 2011 ident: 10.1016/j.breast.2024.103807_bib9 article-title: The molecular pathology of breast cancer progression publication-title: J Pathol doi: 10.1002/path.2808 – volume: 12 start-page: 103 issue: 2 year: 2001 ident: 10.1016/j.breast.2024.103807_bib31 article-title: Effects of mammographic density and benign breast disease on breast cancer risk (United States) publication-title: Cancer Causes Control doi: 10.1023/A:1008935821885 – volume: 40 start-page: 4 year: 2018 ident: 10.1016/j.breast.2024.103807_bib59 article-title: All pure flat atypical atypia lesions of the breast diagnosed using percutaneous vacuum-assisted breast biopsy do not need surgical excision publication-title: Breast doi: 10.1016/j.breast.2018.03.012 – volume: 7 start-page: 341 issue: 4 year: 2000 ident: 10.1016/j.breast.2024.103807_bib74 article-title: Treatment of noninvasive carcinoma: fifteen-year results at the national cancer center hospital in tokyo publication-title: Breast Cancer doi: 10.1007/BF02966402 – volume: 116 start-page: 820 issue: 5 year: 2005 ident: 10.1016/j.breast.2024.103807_bib45 article-title: Invasive breast cancer following ductal and lobular carcinoma in situ of the breast publication-title: Int J Cancer doi: 10.1002/ijc.20870 – volume: 165 start-page: 285 issue: 2 year: 2017 ident: 10.1016/j.breast.2024.103807_bib50 article-title: Reassessing risk models for atypical hyperplasia: age may not matter publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4320-7 – volume: 28 start-page: 3591 issue: 22 year: 2010 ident: 10.1016/j.breast.2024.103807_bib29 article-title: Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia publication-title: J Clin Oncol doi: 10.1200/JCO.2010.28.0784 – volume: 21 start-page: 821 issue: 6 year: 2010 ident: 10.1016/j.breast.2024.103807_bib41 article-title: A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer publication-title: Cancer Causes Control doi: 10.1007/s10552-010-9508-7 – volume: 5 start-page: 1375 issue: 12 year: 2012 ident: 10.1016/j.breast.2024.103807_bib3 article-title: Benign breast disease and the risk of subsequent breast cancer in African American women publication-title: Cancer Prev Res doi: 10.1158/1940-6207.CAPR-12-0175 – volume: 31 start-page: 3120 issue: 5 year: 2024 ident: 10.1016/j.breast.2024.103807_bib16 article-title: Upgrade rates and breast cancer development among germline pathogenic variant carriers with high-risk breast lesions publication-title: Ann Surg Oncol doi: 10.1245/s10434-024-14947-0 – volume: 26 start-page: 421 issue: 4 year: 2002 ident: 10.1016/j.breast.2024.103807_bib69 article-title: Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study publication-title: Am J Surg Pathol doi: 10.1097/00000478-200204000-00003 – volume: 26 start-page: 2350 issue: 12 year: 2020 ident: 10.1016/j.breast.2024.103807_bib70 article-title: Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy publication-title: Breast J doi: 10.1111/tbj.14085 – volume: 125 start-page: 3330 issue: 19 year: 2019 ident: 10.1016/j.breast.2024.103807_bib46 article-title: Risk of breast cancer by prior screening results among women participating in BreastScreen Norway publication-title: Cancer doi: 10.1002/cncr.32330 – volume: 29 start-page: 1660 issue: 3 year: 2022 ident: 10.1016/j.breast.2024.103807_bib44 article-title: Atypical lobular hyperplasia and classic lobular carcinoma in situ can Be safely managed without surgical excision publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-10827-z – volume: 32 start-page: 621 issue: 1 year: 2022 ident: 10.1016/j.breast.2024.103807_bib62 article-title: Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening publication-title: Eur Radiol doi: 10.1007/s00330-021-08118-y – volume: 149 start-page: 569 issue: 3 year: 2015 ident: 10.1016/j.breast.2024.103807_bib11 article-title: Breast cancer risk associated with benign breast disease: systematic review and meta-analysis publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3254-6 – volume: 361 start-page: 125 issue: 9352 year: 2003 ident: 10.1016/j.breast.2024.103807_bib60 article-title: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(03)12230-1 – volume: 24 start-page: 1651 issue: 7 year: 2014 ident: 10.1016/j.breast.2024.103807_bib72 article-title: Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy publication-title: Eur Radiol doi: 10.1007/s00330-014-3132-y – volume: 124 start-page: 459 issue: 3 year: 2018 ident: 10.1016/j.breast.2024.103807_bib36 article-title: Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core-needle biopsy publication-title: Cancer doi: 10.1002/cncr.31061 – volume: 135 start-page: 1646 issue: 7 year: 2014 ident: 10.1016/j.breast.2024.103807_bib77 article-title: Is carcinoma in situ a precursor lesion of invasive breast cancer? publication-title: Int J Cancer doi: 10.1002/ijc.28803 – volume: 92 start-page: 738 issue: 4 year: 2001 ident: 10.1016/j.breast.2024.103807_bib38 article-title: Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast publication-title: Cancer doi: 10.1002/1097-0142(20010815)92:4<738::AID-CNCR1377>3.0.CO;2-Z – ident: 10.1016/j.breast.2024.103807_bib18 – volume: 118 start-page: 1 issue: 1 year: 2009 ident: 10.1016/j.breast.2024.103807_bib83 article-title: Risk factors for breast cancer from benign breast disease in a diverse population publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-008-0198-8 – volume: 21 start-page: 900 issue: 9 year: 2023 ident: 10.1016/j.breast.2024.103807_bib86 article-title: NCCN guidelines(R) insights: breast cancer screening and diagnosis, version 1.2023 publication-title: J Natl Compr Canc Netw doi: 10.6004/jnccn.2023.0046 – volume: 105 start-page: 1043 issue: 14 year: 2013 ident: 10.1016/j.breast.2024.103807_bib75 article-title: Benign breast disease, mammographic breast density, and the risk of breast cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djt124 – volume: 40 start-page: 155 issue: 3 year: 2021 ident: 10.1016/j.breast.2024.103807_bib37 article-title: Upgrade rates and outcomes of screen-detected atypical intraductal epithelial proliferation (AIDEP) diagnosed on core needle biopsy publication-title: Breast Dis doi: 10.3233/BD-201031 – volume: 90 issue: 1071 year: 2017 ident: 10.1016/j.breast.2024.103807_bib13 article-title: The B3 conundrum-the radiologists' perspective publication-title: Br J Radiol doi: 10.1259/bjr.20160595 – volume: 59 start-page: 376 year: 2021 ident: 10.1016/j.breast.2024.103807_bib78 article-title: Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in The Netherlands: a population-based analysis publication-title: Breast doi: 10.1016/j.breast.2021.07.020 – volume: 3 start-page: 36 issue: 1 year: 2017 ident: 10.1016/j.breast.2024.103807_bib17 article-title: Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.3022 – volume: 112 start-page: 2152 issue: 10 year: 2008 ident: 10.1016/j.breast.2024.103807_bib57 article-title: Lobular neoplasia on core needle biopsy does not require excision publication-title: Cancer doi: 10.1002/cncr.23415 – volume: 18 start-page: 463 issue: 2 year: 2011 ident: 10.1016/j.breast.2024.103807_bib80 article-title: Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-1340-5 – volume: 122 start-page: 378 issue: 3 year: 2016 ident: 10.1016/j.breast.2024.103807_bib79 article-title: Clinicopathologic features of breast cancers that develop in women with previous benign breast disease publication-title: Cancer doi: 10.1002/cncr.29766 – volume: 8 start-page: e1027 issue: 8 year: 2020 ident: 10.1016/j.breast.2024.103807_bib2 article-title: Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(20)30215-1 – volume: 27 start-page: 48 issue: 1 year: 2021 ident: 10.1016/j.breast.2024.103807_bib85 article-title: Longitudinal study of breast cancer risk markers publication-title: Breast J doi: 10.1111/tbj.14097 – volume: 71 start-page: 209 issue: 3 year: 2021 ident: 10.1016/j.breast.2024.103807_bib1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 241 start-page: 188 year: 2019 ident: 10.1016/j.breast.2024.103807_bib68 article-title: The influence of age on the histopathology and prognosis of atypical breast lesions publication-title: J Surg Res doi: 10.1016/j.jss.2019.03.047 – volume: 74 start-page: 172 issue: 2 year: 2008 ident: 10.1016/j.breast.2024.103807_bib71 article-title: Lobular neoplasia: is surgical excision warranted? publication-title: Am Surg doi: 10.1177/000313480807400218 – volume: 3 start-page: 492 issue: 3 year: 2014 ident: 10.1016/j.breast.2024.103807_bib52 article-title: Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting publication-title: Cancer Med doi: 10.1002/cam4.223 – volume: 29 start-page: 1029 issue: 7 year: 2022 ident: 10.1016/j.breast.2024.103807_bib42 article-title: Upgrade rates of pure, radiology-pathology concordant lobular neoplasia diagnosed on breast core needle biopsy: is surgical excision warranted? publication-title: Acad Radiol doi: 10.1016/j.acra.2021.09.009 – volume: 15 start-page: 3521 issue: 13 year: 2023 ident: 10.1016/j.breast.2024.103807_bib27 article-title: Breast lesions of uncertain malignant potential (B3) and the risk of breast cancer development: a long-term follow-up study publication-title: Cancers doi: 10.3390/cancers15133521 – volume: 122 start-page: 515 issue: 4 year: 2016 ident: 10.1016/j.breast.2024.103807_bib33 article-title: Breast cancer risk by extent and type of atypical hyperplasia: an update from the Nurses' Health Studies publication-title: Cancer doi: 10.1002/cncr.29775 – volume: 121 start-page: 1548 issue: 10 year: 2015 ident: 10.1016/j.breast.2024.103807_bib65 article-title: Flat epithelial atypia and risk of breast cancer: a Mayo cohort study publication-title: Cancer doi: 10.1002/cncr.29243 – volume: 24 start-page: 208 issue: 3 year: 2015 ident: 10.1016/j.breast.2024.103807_bib30 article-title: Risk profile of breast cancer following atypical hyperplasia detected through organized screening publication-title: Breast doi: 10.1016/j.breast.2015.01.006 – volume: 451 start-page: 883 issue: 5 year: 2007 ident: 10.1016/j.breast.2024.103807_bib49 article-title: Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999) publication-title: Virchows Arch doi: 10.1007/s00428-007-0499-z – volume: 263 start-page: 43 issue: 1 year: 2012 ident: 10.1016/j.breast.2024.103807_bib63 article-title: Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy publication-title: Radiology doi: 10.1148/radiol.11111293 – year: 2019 ident: 10.1016/j.breast.2024.103807_bib22 – volume: 24 start-page: 2509 issue: 9 year: 2017 ident: 10.1016/j.breast.2024.103807_bib81 article-title: Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5867-6 – volume: 20 start-page: 1302 issue: 4 year: 2013 ident: 10.1016/j.breast.2024.103807_bib10 article-title: Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer? publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2719-2 – volume: 276 start-page: e932 issue: 6 year: 2022 ident: 10.1016/j.breast.2024.103807_bib43 article-title: Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision publication-title: Ann Surg doi: 10.1097/SLA.0000000000004849 – volume: 109 start-page: 5 issue: 5 year: 2017 ident: 10.1016/j.breast.2024.103807_bib6 article-title: Risk factors that increase risk of estrogen receptor-positive and -negative breast cancer publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djw276 – volume: 16 issue: 3 year: 2021 ident: 10.1016/j.breast.2024.103807_bib48 article-title: Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening publication-title: PLoS One doi: 10.1371/journal.pone.0248930 – volume: 86 start-page: 1088 issue: 9 year: 2020 ident: 10.1016/j.breast.2024.103807_bib54 article-title: Is excisional biopsy needed for pure FEA diagnosed on a core biopsy? publication-title: Am Surg doi: 10.1177/0003134820943546 – volume: 2 start-page: 90 year: 2010 ident: 10.1016/j.breast.2024.103807_bib8 article-title: Flat epithelial atypia: a review of current concepts publication-title: Open Breast Cancer J – volume: 91 issue: 1085 year: 2018 ident: 10.1016/j.breast.2024.103807_bib67 article-title: Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia publication-title: Br J Radiol doi: 10.1259/bjr.20180003 – year: 2021 ident: 10.1016/j.breast.2024.103807_bib19 – volume: 12 start-page: 471 issue: 7 year: 2019 ident: 10.1016/j.breast.2024.103807_bib61 article-title: Breast hyperplasias, risk signature, and breast cancer publication-title: Cancer Prev Res doi: 10.1158/1940-6207.CAPR-19-0051 – volume: 364 start-page: 2381 issue: 25 year: 2011 ident: 10.1016/j.breast.2024.103807_bib39 article-title: Exemestane for breast-cancer prevention in postmenopausal women publication-title: N Engl J Med doi: 10.1056/NEJMoa1103507 – volume: 216 start-page: 1432 issue: 6 year: 2021 ident: 10.1016/j.breast.2024.103807_bib12 article-title: Management of high-risk breast lesions: point-surveillance is a change in practice preceding evidence-based standardization publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.20.25072 – volume: 27 start-page: 1844 issue: 6 year: 2020 ident: 10.1016/j.breast.2024.103807_bib55 article-title: Do body mass index and breast density impact cancer risk among women with lobular carcinoma in situ? publication-title: Ann Surg Oncol doi: 10.1245/s10434-019-08126-9 – volume: 16 start-page: 507 issue: 6 year: 2016 ident: 10.1016/j.breast.2024.103807_bib73 article-title: Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2016.06.003 – volume: 33 start-page: 3137 issue: 28 year: 2015 ident: 10.1016/j.breast.2024.103807_bib76 article-title: Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2015.60.8869 – volume: 192 start-page: 499 issue: 4 year: 2006 ident: 10.1016/j.breast.2024.103807_bib40 article-title: The significance of surgical margins for patients with atypical ductal hyperplasia publication-title: Am J Surg doi: 10.1016/j.amjsurg.2006.06.024 – volume: 122 start-page: 2971 issue: 19 year: 2016 ident: 10.1016/j.breast.2024.103807_bib35 article-title: Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women publication-title: Cancer doi: 10.1002/cncr.30153 – volume: 29 start-page: 6484 issue: 10 year: 2022 ident: 10.1016/j.breast.2024.103807_bib53 article-title: The influence of body mass index on the histopathology and outcomes of patients diagnosed with atypical breast lesions publication-title: Ann Surg Oncol doi: 10.1245/s10434-022-12313-6 – volume: 13 start-page: 115 issue: 2 year: 2007 ident: 10.1016/j.breast.2024.103807_bib82 article-title: Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population publication-title: Breast J doi: 10.1111/j.1524-4741.2007.00388.x – volume: 107 start-page: 331 issue: 3 year: 2008 ident: 10.1016/j.breast.2024.103807_bib26 article-title: Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-007-9557-0 – volume: 91 issue: 1081 year: 2018 ident: 10.1016/j.breast.2024.103807_bib66 article-title: Flat epithelial atypia: conservative management of patients without residual microcalcifications post-vacuum-assisted breast biopsy publication-title: Br J Radiol doi: 10.1259/bjr.20170484 – volume: 74 start-page: 790 issue: 9 year: 2021 ident: 10.1016/j.breast.2024.103807_bib21 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: Rev Esp Cardiol doi: 10.1016/j.recesp.2021.06.016 – volume: 16 start-page: 467 issue: 3 year: 2007 ident: 10.1016/j.breast.2024.103807_bib25 article-title: Benign breast biopsy diagnosis and subsequent risk of breast cancer publication-title: Cancer Epidemiology Biomarkers and Prevention doi: 10.1158/1055-9965.EPI-06-0394 – volume: 26 start-page: 55 issue: 1 year: 2019 ident: 10.1016/j.breast.2024.103807_bib58 article-title: Evaluating the rate of upgrade to invasive breast cancer and/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6937-0 – volume: 119 start-page: 36 issue: 1 year: 2018 ident: 10.1016/j.breast.2024.103807_bib47 article-title: Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ publication-title: Br J Cancer doi: 10.1038/s41416-018-0120-z – volume: 27 start-page: 3614 issue: 10 year: 2020 ident: 10.1016/j.breast.2024.103807_bib84 article-title: Factors predicting breast cancer development in women during surveillance after surgery for atypical ductal hyperplasia of the breast: analysis of clinical, radiologic, and histopathologic features publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-08476-9 – volume: 50 issue: 1 year: 2024 ident: 10.1016/j.breast.2024.103807_bib14 article-title: European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2023.107292 – volume: 165 start-page: 623 issue: 3 year: 2017 ident: 10.1016/j.breast.2024.103807_bib24 article-title: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-017-4347-9 – volume: 192 start-page: 474 issue: 4 year: 2006 ident: 10.1016/j.breast.2024.103807_bib32 article-title: Predictors of breast cancer development in a high-risk population publication-title: Am J Surg doi: 10.1016/j.amjsurg.2006.06.015 – volume: 149 start-page: 237 issue: 1 year: 2015 ident: 10.1016/j.breast.2024.103807_bib5 article-title: Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3208-z – volume: 51 start-page: 845 issue: 8 year: 2020 ident: 10.1016/j.breast.2024.103807_bib15 article-title: Preneoplasia of the breast and molecular landscape publication-title: Arch Med Res doi: 10.1016/j.arcmed.2020.09.011 – volume: 20 start-page: 464 issue: 6 year: 2014 ident: 10.1016/j.breast.2024.103807_bib23 article-title: Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it? publication-title: Diagn Interv Radiol doi: 10.5152/dir.2014.14023 – volume: 142 start-page: 391 issue: 3 year: 2018 ident: 10.1016/j.breast.2024.103807_bib56 article-title: Isolated atypical lobular hyperplasia diagnosed on breast biopsy: low upgrade rate on subsequent excision with long-term follow-up publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2017-0155-OA – volume: 19 start-page: 80 issue: 1 year: 2021 ident: 10.1016/j.breast.2024.103807_bib51 article-title: The lobular neoplasia enigma: management and prognosis in a long follow-up case series publication-title: World J Surg Oncol doi: 10.1186/s12957-021-02182-w – volume: 353 start-page: 229 issue: 3 year: 2005 ident: 10.1016/j.breast.2024.103807_bib4 article-title: Benign breast disease and the risk of breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa044383 – volume: 136 start-page: 627 issue: 3 year: 2012 ident: 10.1016/j.breast.2024.103807_bib34 article-title: The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2318-8 |
| SSID | ssj0009368 |
| Score | 2.3951054 |
| SecondaryResourceType | review_article |
| Snippet | Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and flat... • Cumulative breast cancer risk varies by time from initial lesion and by lesion type. • Moderate/high breast cancer risk shown within 10 years from initial... Background: Biopsy-proven breast lesions such as atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS) and... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 103807 |
| SubjectTerms | Atypical proliferations Biopsy Breast - pathology Breast cancer Breast cancer risk Breast Carcinoma In Situ - epidemiology Breast Carcinoma In Situ - pathology Breast Neoplasms - epidemiology Breast Neoplasms - pathology Carcinoma, Intraductal, Noninfiltrating - epidemiology Carcinoma, Intraductal, Noninfiltrating - pathology Carcinoma, Lobular - epidemiology Carcinoma, Lobular - pathology Female Humans Hyperplasia - pathology Incidence Lobular carcinoma in-situ Mammography Precancerous Conditions - epidemiology Precancerous Conditions - pathology Review Risk Assessment Risk Factors |
| SummonAdditionalLinks | – databaseName: Elsevier ScienceDirect dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhAXxJvwkpE4NmwezotbqagqpHIplXqzxrFNg7ZJlGYPXPhD_Elm7CRt4ADiFMVre2PP2P5GnvmGsbeqBJNR1oCiBh2KOoYQQEGI6w43TE2Jaig4-fRzfnIuPl1kF3vsaI6FIbfKae_3e7rbraeSzTSbm75pNmeOLK3AToW7biPGTyEK0vJ3P27cPKrUhcNR5ZBqz-FzzsdLkeM3eVQmwjGFU1LZW8eTY_FfnVJ_otDfnSlvnU7H99m9CVbyQ__lD9ieaR-yO6fTxfkj9vNw_N6TPDjxu-KjG_i2U-SDyi_RFB16F055sBTWlGOo7a6AN2143Yy7A263MHLTUxDHFrWWA3WJTaDV3FOTcHJU553lN6FY3A8e-8OZHd7zs4U5mvuoGdf8yowovYkf5TE7P_745egknPI0hHWWJmOYVKrUtozzyBJ7WGFyk0bK5gryooASreA6TiEFE5e2Irp9Y8s6QZyWWWF1KdInbL_tWvOM8SxFuavIAuIUAVUCWS0ijZZzlqIha03Awlk8svd0HHL2U_sm_YgkiVN6cQbsA8lwqUtk2q6gG77KSZuksmAKU-scchAIGCvQiPvyCOJYE4F_wLJZA-Qcr4o7LHbU_OXPi6XdSqf_oeWbWdEkLne6w4HWdLtriWgc5wItoiRgT73iLYNDqFsgAk8DVq5UcjX69S9tc-koxdEqRmBZVs__-5NfsLv05j19XrL9cdiZV4jXRvXaLchfl3ZCNw priority: 102 providerName: Elsevier |
| Title | Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0960977624001383 https://dx.doi.org/10.1016/j.breast.2024.103807 https://www.ncbi.nlm.nih.gov/pubmed/39270543 https://www.proquest.com/docview/3104537292 https://pubmed.ncbi.nlm.nih.gov/PMC11415589 https://doaj.org/article/bfae7ecd6a6a48399ad61260a11d4260 |
| Volume | 78 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgL4k14rIzEsYEkzsPhtqBWC6v2AFT0Zo1jW120TVbb7IELf4g_yUychN32UA49RUrWzo5n7PlGmfmGsbdags2oa0BRgQnTKoYQQEOI-w4PTEONaqg4-eg4n52kX06z061WX5QT5umB_cK91w5sYSuTQw4pevMSDDrlPII4NsSuTqcv-rwhmBrodkUuh0K5LptLU4o35U4maccJTu1jtxxRx9e_44-u4s3LaZNbfujwAbvfA0g-9X_8Ibtl60fs7lH_ifwx-zNtf61o5TkxueKlWfNloynblJ9h0LledYWT--PNiroJ1c058EUdXizazT53S2i5XVG5xhLtkwNNiUOgNtyTkHBKSeeN4_-KrrgXHudDO1p_4N9Gjmju62O64ee2RT31TChP2MnhwfdPs7DvyBBWmUjaMCm1NE7GeeSIJ6ywuRWRdrmGvChAYrxbxQIE2Fi6koj1rZNVgogsc6kzMhVP2V7d1PY545morNGRA0QkKZQJZFUaGYyRM4Ehq7MBCwf1qJUn3lBDRtpP5SVSpE7l1Rmwj6TD8bdEm93dQGNSvTGp64wpYNlgAWqoTMWzFCdaXPPyYhzXIxePSP5j5JvB0BRubPpaA7VtNhcKcTeuBcY-ScCeecMbhUNQWyDWFgGTOya5I_3uk3px1pGHY_yLEFKWL25ivV6yeySLT-95xfba9ca-RpDW6gm7_e53PGF3pp_ns2O6zr_-mE-6XfoXCjxDyw |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbKVgIuiDfhaSSOjTbvB7elotrS7l7aSr1Zk8Rug7ZJlGYP_U39k8zYSdrAAcRpJSfjjT1j-xt55hvGvmQJyJCqBsQ5FHaQu2ADZGDjusMNs6BCNZScvFpHy7Pgx3l4vsP2h1wYCqvs936zp-vdum-Z97M5b8pyfqLJ0mLsNNDXbf4DtkvsVOGM7S4Oj5brO-5dX2fE0fs2CQwZdDrMK6PYbwqq9AJNFk51Ze-dUJrIf3JQ_QlEf4-nvHdAHTxlT3pkyRfm45-xHVk9Zw9X_d35C3a76G4aUgknilf8qVu-qTMKQ-WX6I22jc6o3BsbcyozVNVXwMvKvi677R5XG-i4bCiPY4OGy4G6RBGoCm7YSTjFqvNa8btsLG4Gj_3h5LZf-clIHs1N4owWv5IdKrCnSHnJzg6-n-4v7b5Ug52HvtfZXpolhUrcyFFEIBbLSPpOpqIMojiGBB3h3PXBB-kmKiXGfamS3EOoFqpAFUngv2Kzqq7kG8ZDH1WfOQoQqgSQehDmgVOg8xz66MsqaTF7UI9oDCOHGELVfgozIkHqFEadFvtGOhzfJT5t3VC3F6I3KJEpkLHMiwgiCBAzplAg9IsccN2COPwtFg4WIIaUVdxksaPyL38ej3ITs_4Hyc-DoQlc8XSNA5Wst9cCATnOBTpFnsVeG8MbB4doN0YQ7lssmZjkZPTTJ1V5qVnF0TFGbJmkb__7kz-xR8vT1bE4PlwfvWOP6YkJ_HnPZl27lR8QvnXZx355_gKZA0Z2 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atypical+ductal+or+lobular+hyperplasia%2C+lobular+carcinoma+in-situ%2C+flat+epithelial+atypia%2C+and+future+risk+of+developing+breast+cancer%3A+Systematic+review+and+meta-analysis&rft.jtitle=Breast+%28Edinburgh%29&rft.au=Jannah+Baker&rft.au=Naomi+Noguchi&rft.au=M+Luke+Marinovich&rft.au=Brian+L.+Sprague&rft.date=2024-12-01&rft.pub=Elsevier&rft.eissn=1532-3080&rft.volume=78&rft.spage=103807&rft_id=info:doi/10.1016%2Fj.breast.2024.103807&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bfae7ecd6a6a48399ad61260a11d4260 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-9776&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-9776&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-9776&client=summon |